Details for Patent: 9,155,471
✉ Email this page to a colleague
Which drugs does patent 9,155,471 protect, and when does it expire?
Patent 9,155,471 protects LUMISIGHT and is included in one NDA.
This patent has nine patent family members in four countries.
Summary for Patent: 9,155,471
Title: | Methods and systems for spatially identifying abnormal cells |
Abstract: | The present invention provides compositions and methods for imaging tumor resections. |
Inventor(s): | Lee W. David, Bawendi Moungi G., Ferrer Jorge |
Assignee: | Lumicell, Inc'. |
Application Number: | US12958058 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 9,155,471
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lumicell | LUMISIGHT | pegulicianine acetate | POWDER;INTRAVENOUS | 214511-001 | Apr 17, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | A METHOD COMPRISING ADMINISTERING PEGULICIANINE TO A HUMAN AND OBTAINING AN IMAGE OF A TUMOR BED AFTER TUMOR RESECTION TO DISTINGUISH IN SITU CANCER CELLS FROM HEALTHY CELLS | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,155,471
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011336660 | ⤷ Sign Up | |||
Australia | 2016277654 | ⤷ Sign Up | |||
Canada | 2824724 | ⤷ Sign Up | |||
Canada | 3080998 | ⤷ Sign Up | |||
European Patent Office | 2435096 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |